SRXH dividend history

NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that the Board of Directors has approved a one-time cash dividend of $0.05 per share (approximately $1 million in the aggregate) on common stock outstanding to shareholders of record at the close of business on July 22, 2026 (the "Record Date"). The dividend will be paid on or about August 3, 2026 to shareholders of record on Record Date. "This special dividend reflects the strength of our investment strategy and our commitment to returning value direct

NORTH PALM BEACH, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced board approval to dividend 75% of profits from investment in Astro Investment XVII, an affiliate of Astro Capital and special purpose vehicle (SPV), with investments in SpaceX and other artificial intelligence and space companies. The Company recently announced an investment of greater than 10% of its investable capital in Astro Investment XVII and will return capital to shareholders upon wind down of the SPV. F

+5.69% return for shareholders compares to -4.98% decline on the S&P 500 index SRx Health Board of Directors to consider implementing a quarterly dividend policy based on percentage of profits from portfolio NORTH PALM BEACH, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced returning +5.69% in March 2026 in its hedging pool driven by the EMJX artificial intelligence (AI) engine as compared to a decline of -4.98% on the S&P 500 index. Michael Young, Director of SRx Health, co